Urtica dioica extract attenuates depressive like behavior and associative memory dysfunction in dexamethasone induced diabetic mice

Metab Brain Dis. 2014 Mar;29(1):121-30. doi: 10.1007/s11011-014-9480-0. Epub 2014 Jan 17.

Abstract

Evidences suggest that glucocorticoids results in depression and is a risk factor for type 2 diabetes. Further diabetes induces oxidative stress and hippocampal dysfunction resulting in cognitive decline. Traditionally Urtica dioica has been used for diabetes mellitus and cognitive dysfunction. The present study investigated the effect of the hydroalcoholic extract of Urtica dioica leaves (50 and 100 mg/kg, p.o.) in dexamethasone (1 mg/kg, i.m.) induced diabetes and its associated complications such as depressive like behavior and cognitive dysfunction. We observed that mice administered with chronic dexamethasone resulted in hypercortisolemia, oxidative stress, depressive like behavior, cognitive impairment, hyperglycemia with reduced body weight, increased water intake and decreased hippocampal glucose transporter-4 (GLUT4) mRNA expression. Urtica dioica significantly reduced hyperglycemia, plasma corticosterone, oxidative stress and depressive like behavior as well as improved associative memory and hippocampal GLUT4 mRNA expression comparable to rosiglitazone (5 mg/kg, p.o.). Further, Urtica dioica insignificantly improved spatial memory and serum insulin. In conclusion, Urtica dioica reversed dexamethasone induced hyperglycemia and its associated complications such as depressive like behavior and cognitive dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology
  • Antidepressive Agents / therapeutic use*
  • Association Learning / drug effects*
  • Avoidance Learning / drug effects
  • Blood Glucose / analysis
  • Corticosterone / blood
  • Depression / drug therapy*
  • Depression / etiology
  • Dexamethasone / toxicity
  • Diabetes Mellitus, Experimental / blood
  • Diabetes Mellitus, Experimental / chemically induced
  • Diabetes Mellitus, Experimental / drug therapy
  • Diabetes Mellitus, Experimental / psychology*
  • Diabetes Mellitus, Type 2 / blood
  • Diabetes Mellitus, Type 2 / chemically induced
  • Diabetes Mellitus, Type 2 / drug therapy
  • Diabetes Mellitus, Type 2 / psychology*
  • Drug Evaluation, Preclinical
  • Female
  • Glucose Transporter Type 4 / biosynthesis
  • Glucose Transporter Type 4 / genetics
  • Hippocampus / drug effects
  • Hippocampus / metabolism
  • Hypoglycemic Agents / pharmacology
  • Hypoglycemic Agents / therapeutic use*
  • Immobilization
  • Insulin / blood
  • Male
  • Maze Learning / drug effects
  • Memory Disorders / drug therapy*
  • Memory Disorders / etiology
  • Mice
  • Oxidative Stress / drug effects
  • Phytotherapy*
  • Plant Extracts / pharmacology
  • Plant Extracts / therapeutic use*
  • RNA, Messenger / biosynthesis
  • Rosiglitazone
  • Stress, Psychological / blood
  • Stress, Psychological / drug therapy
  • Swimming
  • Thiazolidinediones / pharmacology
  • Thiazolidinediones / therapeutic use
  • Urtica dioica*

Substances

  • Antidepressive Agents
  • Blood Glucose
  • Glucose Transporter Type 4
  • Hypoglycemic Agents
  • Insulin
  • Plant Extracts
  • RNA, Messenger
  • Slc2a4 protein, mouse
  • Thiazolidinediones
  • Rosiglitazone
  • Dexamethasone
  • Corticosterone